E A Musgrove - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

E A Musgrove

Showing results (61-70 of 66) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 66 results.

British Journal of Cancer|December 11, 2008

BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breastE K A Millar, L R Anderson, C M McNeil, et al.

Molecular Endocrinology (Baltimore, Md.)|June 4, 2010

The antiproliferative effects of progestins in T47D breast cancer cells are tempered by progestin induction of the ETS transcription factor Elf5H N Hilton, M Kalyuga, M J Cowley, et al.

British Journal of Cancer|January 31, 2008

Expression of LMO4 and outcome in pancreatic ductal adenocarcinomaN C Murphy, C J Scarlett, J G Kench, et al.

Oncogene|September 25, 1998

EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survivalR Hui, J R Ball, R D Macmillan, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2012

The prognostic and predictive value of serum CA19.9 in pancreatic cancerJ L Humphris, D K Chang, A L Johns, et al.

Oncogene|March 17, 2009

Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcomeE K A Millar, J L Dean, C M McNeil, et al.

Pageof 7

Search research articles

Showing results (61-70 of 66) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 66 results.

British Journal of Cancer|December 11, 2008

BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breastE K A Millar, L R Anderson, C M McNeil, et al.

Molecular Endocrinology (Baltimore, Md.)|June 4, 2010

The antiproliferative effects of progestins in T47D breast cancer cells are tempered by progestin induction of the ETS transcription factor Elf5H N Hilton, M Kalyuga, M J Cowley, et al.

British Journal of Cancer|January 31, 2008

Expression of LMO4 and outcome in pancreatic ductal adenocarcinomaN C Murphy, C J Scarlett, J G Kench, et al.

Oncogene|September 25, 1998

EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survivalR Hui, J R Ball, R D Macmillan, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2012

The prognostic and predictive value of serum CA19.9 in pancreatic cancerJ L Humphris, D K Chang, A L Johns, et al.

Oncogene|March 17, 2009

Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcomeE K A Millar, J L Dean, C M McNeil, et al.

Pageof 7